Target intelligence / Profile preview

Peptidoglycan synthesis in Staphylococcus aureus

Molecular classification
Enzyme (Penicillin-binding proteins, autolysins), Receptor (regulatory two-component systems), Other (peptidoglycan biosynthesis pathway)
01

Overview

The term "Methicillin-sensitive Staphylococcus aureus cell wall synthesis" does not refer to a single molecule, receptor, or protein, but rather to a complex cellular process centered on the **biosynthesis of peptidoglycan**, the main structural component of the Staphylococcus aureus cell wall[1][2][4]. This process mainly involves enzymes known as **penicillin-binding proteins (PBPs)**, with PBP1 and PBP2 being essential for cross-linking peptidoglycan strands[4][5]. Autolysins such as Atl mediate necessary cell wall remodeling and division[2][10]. Cell wall synthesis is a critical bacterial function, targeted by several major antibiotic classes, including β-lactams (such as methicillin and oxacillin) and glycopeptides (such as vancomycin), which collectively disrupt or inhibit peptidoglycan transformations required for cell growth and viability[3][5][7]. Modulators of peptidoglycan synthesis and associated structures, like wall teichoic acids, are also under investigation as novel antibacterial targets[6][9]. Disruption of this pathway leads to bactericidal outcomes, making the pathway (and its key enzymes) central to antibiotic therapy and resistance (notably methicillin resistance in MRSA through acquisition of alternative PBPs)[7]. Because this entry refers to a process rather than a defined target protein, for structured data, it is best mapped to the core target enzymes: *Staphylococcus aureus penicillin-binding protein 2* (PBP2) for methicillin-sensitive strains, and additionally PBP2a for methicillin resistance.

Other names
Staphylococcus aureus cell wall biosynthesisS. aureus peptidoglycan synthesisStaphylococcal cell wall synthesis
02

Mechanism of action

Inhibition of penicillin-binding proteins (PBPs) blocks transpeptidase activity for peptidoglycan crosslinking, causing cell lysis (β-lactams, including methicillin, oxacillin)[5][7][4]. Glycopeptides (vancomycin, telavancin) inhibit septum constriction by blocking transglycosylation during peptidoglycan synthesis[3]. Inhibition of wall teichoic acid synthesis (targocil, tunicamycin) destabilizes cell wall integrity and can resensitize bacteria to β-lactams[6][9].

03

Biological functions

Maintenance of cellular integrityCell shape and divisionResistance to osmotic stressRegulation of autolysisVirulence factor anchoring
04

Disease associations

Infection (bacterial pathogenicity)Antibiotic resistance (e.g., MRSA and resistance emergence)
05

Safety considerations

Toxicity to human microbiota due to broad-spectrum actionResistance emergence (e.g., PBP2a for MRSA)[7]Off-target effects in combination therapy
06

Interacting drugs

Methicillin

6 more in the full profile.

07

Biomarkers

Presence of PBPs (especially PBP2 and PBP2a, the latter in MRSA)[4][7]Mutations or expression changes in regulatory systems (WalKR, VraSR)[2][8]Peptidoglycan or wall teichoic acid levels (research stage)

Beyond the preview

Go deeper on Peptidoglycan synthesis in Staphylococcus aureus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidoglycan synthesis in Staphylococcus aureus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call